ABCL - CIK 0001703057
AbCellera Biologics Inc. has filed 297 documents with the SEC between 2017 and 2026. The most frequent type is insider trade (109 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2026-05-18 | 2026-05-14 |
| Quarterly report | 10-Q | 2026-05-11 | 2026-03-31 |
| Major company event | 8-K | 2026-05-11 | 2026-05-11 |
| SCHEDULE 13G/A | - | 2026-05-07 | - |
| Annual report to shareholders | ARS | 2026-04-29 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-04-29 | - |
| Proxy statement | DEF 14A | 2026-04-29 | 2025-12-31 |
| Insider trade | 4 | 2026-03-02 | 2026-02-27 |
| Insider trade | 4 | 2026-02-27 | 2026-02-26 |
| Insider trade | 4 | 2026-02-27 | 2026-02-27 |
| Employee stock plan | S-8 | 2026-02-24 | - |
| Annual report | 10-K | 2026-02-24 | 2025-12-31 |
| Major company event | 8-K | 2026-02-24 | 2026-02-24 |
| Major company event | 8-K | 2026-01-14 | 2026-01-12 |
| Insider trade | 4 | 2026-01-05 | 2026-01-01 |
| Insider trade | 4 | 2026-01-05 | 2026-01-01 |
| Insider trade | 4 | 2026-01-05 | 2026-01-01 |
| Insider trade | 4 | 2026-01-05 | 2026-01-01 |
| Insider trade | 4 | 2025-12-19 | 2025-12-18 |
| Insider trade | 4 | 2025-12-19 | 2025-12-01 |
| New insider ownership | 3 | 2025-12-19 | 2025-11-10 |
| Major company event | 8-K | 2025-12-18 | 2025-12-18 |
| Major company event | 8-K | 2025-11-28 | 2025-11-24 |
| Insider trade | 4 | 2025-11-26 | 2025-11-26 |
| Major company event | 8-K | 2025-11-12 | 2025-11-10 |
| Quarterly report | 10-Q | 2025-11-06 | 2025-09-30 |
| Major company event | 8-K | 2025-11-06 | 2025-11-06 |
| Major company event | 8-K | 2025-09-10 | 2025-09-10 |
| Quarterly report | 10-Q | 2025-08-07 | 2025-06-30 |
| Major company event | 8-K | 2025-08-07 | 2025-08-07 |
| Insider trade | 4 | 2025-07-01 | 2025-06-12 |
| Insider trade | 4 | 2025-06-16 | 2025-06-12 |
| Insider trade | 4 | 2025-06-16 | 2025-06-12 |
| Major company event | 8-K | 2025-06-13 | 2025-06-12 |
| Major company event | 8-K | 2025-05-30 | 2025-05-30 |
| Major company event | 8-K | 2025-05-14 | 2025-05-14 |
| Major company event | 8-K | 2025-05-13 | 2025-05-12 |
| Quarterly report | 10-Q | 2025-05-08 | 2025-03-31 |
| Major company event | 8-K | 2025-05-08 | 2025-05-08 |
| Annual report to shareholders | ARS | 2025-04-29 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-04-29 | - |
| Proxy statement | DEF 14A | 2025-04-29 | 2024-12-31 |
| Insider trade | 4 | 2025-03-11 | 2025-03-11 |
| Insider trade | 4 | 2025-03-10 | 2025-03-10 |
| Insider trade | 4 | 2025-03-07 | 2025-03-06 |
| Employee stock plan | S-8 | 2025-02-27 | - |
| Annual report | 10-K | 2025-02-27 | 2024-12-31 |
| Major company event | 8-K | 2025-02-27 | 2025-02-27 |
| S-3ASR | - | 2025-02-27 | - |
| Major company event | 8-K | 2025-02-18 | 2025-02-18 |